The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crank, J. (1956) · CERN Document Server (European Organization for Nuclear Research) · Cited by 18,978
Park, G. S. (1975) · Polymer · doi:10.1016/0032-3861(75)90130-5 · Cited by 14,967
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Improved tumor perfusion and convective flow may also be achieved by vascular ‘normalization’ with anti-angiogenic drugs [149,150].”
BackgroundTrastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Engineered antibody fragments and the rise of single domains
Holliger, P., & Hudson, P. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1142 · Cited by 1,931
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Biology of the Laboratory Mouse
HESTON, W. E. (1967) · Journal of Heredity · doi:10.1093/oxfordjournals.jhered.a107528 · Cited by 1,394
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Hindered transport of large molecules in liquid‐filled pores
Deen, W. M. (1987) · AIChE Journal · doi:10.1002/aic.690330902 · Cited by 1,186
Arming antibodies: prospects and challenges for immunoconjugates
Wu, A. M., & Senter, P. D. (2005) · Nature Biotechnology · doi:10.1038/nbt1141 · Cited by 1,052
Roberts, W. G., & Palade, G. E. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.6.2369 · Cited by 1,033
Schoeberl, B., Eichler-Jonsson, C., Gilles, E. D., & Müller, G. (2002) · Nature Biotechnology · doi:10.1038/nbt0402-370 · Cited by 950
Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers
Dreher, M. R., Liu, W., Michelich, C. R., Dewhirst, M. W., Yuan, F., & Chilkoti, A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj070 · Cited by 920
Pathophysiological consequences of VEGF-induced vascular permeability
Weis, S. M., & Cheresh, D. A. (2005) · Nature · doi:10.1038/nature03987 · Cited by 909
Antibody Pharmacokinetics and Pharmacodynamics
Lobo, E. D., Hansen, R. J., & Balthasar, J. P. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20178 · Cited by 909
Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection
Baxter, L. T., & Jain, R. K. (1989) · Microvascular Research · doi:10.1016/0026-2862(89)90074-5 · Cited by 894
Biology of the Laboratory Mouse
(1941) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1941.02820440081034 · Cited by 802
Inai, T., Mancuso, M., Hashizume, H., Baffert, F., Haskell, A., Baluk, P., Hu-Lowe, D. D., Shalinsky, D. R., Thurston, G., Yancopoulos, G. D., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63273-7 · Cited by 757
The physiology of the lymphatic system
Swartz, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00150-8 · Cited by 737
Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., & Jain, R. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14765 · Cited by 719
Transport of Molecules, Particles, and Cells in Solid Tumors
Jain, R. K. (1999) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.1.1.241 · Cited by 691
Adams, G. P., Schier, R., McCall, A. M., Simmons, H. H., Horak, E. M., Alpaugh, R. K., Marks, J. D., & Weiner, L. M. (2001) · PubMed · Cited by 629
Microvascular permeability of normal and neoplastic tissues
Gerlowski, L. E., & Jain, R. K. (1986) · Microvascular Research · doi:10.1016/0026-2862(86)90018-x · Cited by 622
Jain, R. K., Tong, R. T., & Munn, L. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4102 · Cited by 612
General Pharmacokinetic Model for Drugs Exhibiting Target-Mediated Drug Disposition
Mager, D. E., & Jusko, W. J. (2001) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1023/a:1014414520282 · Cited by 605
Pluen, A., Boucher, Y., Ramanujan, S., McKee, T. D., Gohongi, T., di Tomaso, E., Brown, E. B., Izumi, Y., Campbell, R. B., Berk, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081626898 · Cited by 603
Rosenstein, M., Ettinghausen, S. E., & Rosenberg, S. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.5.1735 · Cited by 530
Boucher, Y., & Jain, R. K. (1992) · PubMed · Cited by 510
Sparreboom, A., Scripture, C. D., Trieu, V., Williams, P. J., De, T., Yang, A., Beals, B., Figg, W. D., Hawkins, M., & Desai, N. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2291 · Cited by 504
Austin, C. D., De Mazière, A. M., Pisacane, P. I., van Dijk, S. M., Eigenbrot, C., Sliwkowski, M. X., Klumperman, J., & Scheller, R. H. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-07-0591 · Cited by 496
Induction of a bystander mutagenic effect of alpha particles in mammalian cells
Zhou, H., Randers-Pehrson, G., Waldren, C. A., Vannais, D., Hall, E. J., & Hei, T. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030420797 · Cited by 477
Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., & Maeda, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00563.x · Cited by 470
Constitutive and antibody-induced internalization of prostate-specific membrane antigen.
Liu, H., Rajasekaran, A. K., Moy, P., Xia, Y., Kim, S., Navarro, V., Rahmati, R., & Bander, N. H. (1998) · PubMed · Cited by 458
Intermittent blood flow in a murine tumor: radiobiological effects.
Chaplin, D. J., Olive, P. L., & Durand, R. E. (1987) · PubMed · Cited by 436
The seed and soil hypothesis: vascularisation and brain metastases
Fidler, I. J., Yano, S., Zhang, R.-D., Fujimaki, T., & Bucana, C. D. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00622-2 · Cited by 432
Lyng, H., Haraldseth, O., & Rofstad, E. K. (2000) · Magnetic Resonance in Medicine · doi:10.1002/1522-2594(200006)43:6<828::aid-mrm8>3.0.co;2-p · Cited by 431
Structural determinants of glomerular permeability
Deen, W. M., Lazzara, M. J., & Myers, B. D. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.4.f579 · Cited by 413
Juweid, M. E., Neumann, R. D., Paik, C. H., Pérez-Bacete, M., Sato, J., van Osdol, W. W., & Weinstein, J. N. (1992) · PubMed · Cited by 406
Schier, R., McCall, A., Adams, G. P., Marshall, K. W., Merritt, H., Yim, M., Crawford, R. S., Weiner, L. M., Marks, C., & Marks, J. D. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0598 · Cited by 382
Transport of fluid and macromolecules in tumors
Baxter, L. T., & Jain, R. K. (1991) · Microvascular Research · doi:10.1016/0026-2862(91)90003-t · Cited by 368
A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier.
Fujimori, K., Covell, D. G., Fletcher, J. E., & Weinstein, J. N. (1990) · PubMed · Cited by 356
Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy
Goldenberg, D. M., Sharkey, R. M., Paganelli, G., Barbet, J., & Chatal, J.-F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8471 · Cited by 351
Therapeutic antibody fragments with prolonged in vivo half-lives
Chapman, A. P., Antoniw, P., Spitali, M., West, S., Stephens, S., & King, D. J. (1999) · Nature Biotechnology · doi:10.1038/11717 · Cited by 350
Domain antibodies: proteins for therapy
Holt, L. J., Herring, C., Jespers, L. S., Woolven, B. P., & Tomlinson, I. M. (2003) · Trends in Biotechnology · doi:10.1016/j.tibtech.2003.08.007 · Cited by 345
Milenic, D. E., Yokota, T., Filpula, D. R., Finkelman, M., Dodd, S. W., Wood, J. F., Whitlow, M. D., Snoy, P. J., & Schlom, J. (1991) · PubMed · Cited by 338
Pharmacologic target-mediated drug disposition
Levy, G. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.134 · Cited by 332
Hu, S., Shively, L., Raubitschek, A. A., Sherman, M. A., Williams, L. E., Wong, J. Y., Shively, J. E., & Wu, A. M. (1996) · PubMed · Cited by 330
Garg, A., & Balthasar, J. P. (2007) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-007-9065-1 · Cited by 327
Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma.
Knox, S. J., Goris, M. L., Trisler, K. D., Negrin, R. S., Davis, T., Liles, T. M., Grillo-López, A. J., Chinn, P. C., Varns, C., Ning, S., et al. (1996) · PubMed · Cited by 326
Worthylake, R., Opresko, L. K., & Wiley, H. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8865 · Cited by 325
Extravascular diffusion in normal and neoplastic tissues.
Nugent, L. J., & Jain, R. K. (1984) · PubMed · Cited by 316
Baxter, L. T., Zhu, H. J., Mackensen, D. G., & Jain, R. K. (1994) · PubMed · Cited by 284
Baish, J. W., Gazit, Y., Berk, D. A., Nozue, M., Baxter, L. T., & Jain, R. K. (1996) · Microvascular Research · doi:10.1006/mvre.1996.0031 · Cited by 274
Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer
John, T. A., Vogel, S. M., Tiruppathi, C., Malik, A. B., & Minshall, R. D. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00152.2002 · Cited by 269
Netti, P. A., Baxter, L. T., Boucher, Y., Skalak, R., & Jain, R. K. (1995) · PubMed · Cited by 263
Friedman, L. M., Rinon, A., Schechter, B., Lyass, L., Lavi, S., Bacus, S. S., Sela, M., & Yarden, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409610102 · Cited by 252
Galaup, A., Cazes, A., Le Jan, S., Philippe, J., Connault, E., Le Coz, E., Mekid, H., Mir, L. M., Opolon, P., Corvol, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609025103 · Cited by 252
Imaging Tumors with an Albumin-Binding Fab, a Novel Tumor-Targeting Agent
Dennis, M. S., Jin, H., Dugger, D., Yang, R., McFarland, L., Ogasawara, A., Williams, S., Cole, M. J., Ross, S., & Schwall, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2531 · Cited by 251
Target-mediated drug disposition and dynamics
Mager, D. E. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.041 · Cited by 244
Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies.
Adams, G. P., Schier, R., Marshall, K., Wolf, E. J., McCall, A. M., Marks, J. D., & Weiner, L. M. (1998) · PubMed · Cited by 230
Factors determining antibody distribution in tumors
THURBER, G., SCHMIDT, M., & WITTRUP, K. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.11.004 · Cited by 223
Self-citationMüller, D., Karle, A., Meißburger, B., Höfig, I., Stork, R., & Kontermann, R. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700820200 · Cited by 222
Sundaresan, G., Yazaki, P. J., Shively, J. E., Finn, R. D., Larson, S. M., Raubitschek, A. A., Williams, L. E., Chatziioannou, A. F., Gambhir, S. S., & Wu, A. M. (2003) · PubMed · Cited by 222
(2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1171 · Cited by 219
McIntosh, D. P., Tan, X.-Y., Oh, P., & Schnitzer, J. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251662398 · Cited by 210
Adams, G., Schier, R., McCall, A., Crawford, R., Wolf, E., Weiner, L., & Marks, J. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.233 · Cited by 208
Press, O. W., Shan, D., Howell-Clark, J., Eary, J. F., Appelbaum, F. R., Matthews, D. C., King, D. J., Haines, A. M. R., Hamann, P., Hinman, L. M., et al. (1996) · PubMed · Cited by 207
Kenanova, V., Olafsen, T., Crow, D. M., Sundaresan, G., Subbarayan, M., Carter, N. H., Ikle, D. N., Yazaki, P. J., Chatziioannou, A. F., Gambhir, S. S., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.622.65.2 · Cited by 206
Graff, C. P., & Wittrup, K. D. (2003) · PubMed · Cited by 205
Self-citationEnhancement of fluid filtration across tumor vessels: Implication for delivery of macromolecules
Netti, P. A., Hamberg, L. M., Babich, J. W., Kierstead, D., Graham, W., Hunter, G. J., Wolf, G. L., Fischman, A., Boucher, Y., & Jain, R. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3137 · Cited by 202
RIPPE, B., & HARALDSSON, B. (1987) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1987.tb08257.x · Cited by 170
Cancer radioimmunotherapy with alpha-emitting nuclides
Couturier, O., Supiot, S., Degraef-Mougin, M., Faivre-Chauvet, A., Carlier, T., Chatal, J.-F., Davodeau, F., & Cherel, M. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1803-2 · Cited by 170
Transcytosis and Catabolism of Antibody
Ghetie, V. F., & Ward, E. S. (2002) · Immunologic Research · doi:10.1385/ir:25:2:097 · Cited by 163
Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells
Tiruppathi, C., Naqvi, T., Wu, Y., Vogel, S. M., Minshall, R. D., & Malik, A. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401712101 · Cited by 159
Microvascular studies on the origins of perfusion-limited hypoxia.
Dewhirst, M. W., Kimura, H., Rehmus, W., Braun, R. D., Papahadjopoulos, D., Hong, K., & Secomb, T. W. (1996) · Europe PMC (PubMed Central) · Cited by 157
Sutherland, R. M., Buchegger, F., Schreyer, M., Vacca, A., & Mach, J. (1987) · PubMed · Cited by 151
Theoretic Criteria for Antibody Penetration into Solid Tumors and Micrometastases
Thurber, G. M., Zajic, S. C., & Wittrup, K. D. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.037069 · Cited by 146
Self-citationDirect in vivo measurement of targeted binding in a human tumor xenograft
Berk, D. A., Fan, Y., Leunig, M., & Jain, R. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1785 · Cited by 145
Ferl, G. Z., Wu, A. M., & DiStefano, J. J. (2005) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-7410-3 · Cited by 142
Nguyen, A., Reyes, A. E., Zhang, M., McDonald, P., Wong, W., Damico, L. A., & Dennis, M. S. (2006) · Protein Engineering Design and Selection · doi:10.1093/protein/gzl011 · Cited by 141
STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake.
Pietras, K., Stumm, M., Hubert, M., Buchdunger, E., Rubin, K., Heldin, C., McSheehy, P. M. J., Wartmann, M., & Östman, A. (2003) · PubMed · Cited by 141
Tang, Y., Lou, J., Alpaugh, R. K., Robinson, M. K., Marks, J. D., & Weiner, L. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2815 · Cited by 135
Effect of radiation on interstitial fluid pressure and oxygenation in a human tumor xenograft.
Znati, C. A., Rosenstein, M., Boucher, Y., Epperly, M. W., Bloomer, W. D., & Jain, R. K. (1996) · PubMed · Cited by 131
The Pharmacology of Monoclonal Antibodiesa
Weinstein, J. N., Eger, R. R., Covell, D. G., BLACK, C. D. V., Mulshine, J. L., Carrasquillo, J. A., Larson, S. M., & Keenan, A. M. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb45802.x · Cited by 127
Behr, T. M., Béhé, M. P., Stabin, M. G., Wehrmann, E., Apostolidis, C., Molinet, R., Strutz, F., Fayyazi, A., Wieland, E., Gratz, S., et al. (1999) · PubMed · Cited by 127
van Bueren, J. J. L., Bleeker, W. K., Bøgh, H. O., Houtkamp, M., Schuurman, J., van de Winkel, J. G. J., & Parren, P. W. H. I. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4010 · Cited by 127
PEGylation and Multimerization of the Anti-p185HER-2 Single Chain Fv Fragment 4D5
Kubetzko, S., Balic, E., Waibel, R., Zangemeister‐Wittke, U., & Plückthun, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604127200 · Cited by 124
Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability
Criscuoli, M. L., Nguyen, M. T. N., & Eliceiri, B. P. (2004) · Blood · doi:10.1182/blood-2004-06-2246 · Cited by 121
Davies, C. D. L., Berk, D. A., Pluen, A., & Jain, R. K. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600270 · Cited by 121
Sands, H., Jones, P. L., Shah, S., Palme, D. F., Vessella, R. L., & Gallagher, B. M. (1988) · PubMed · Cited by 119
Yang, K., Basu, A., Wang, M., Chintala, R., Hsieh, M.-C., Liu, S., Hua, J., Zhang, Z., Zhou, J. M., Li, M., et al. (2003) · Protein Engineering Design and Selection · doi:10.1093/protein/gzg093 · Cited by 119
Recommendations for Off-Label Use of Intravenously Administered Immunoglobulin Preparations
Ratko, T. A. (1995) · JAMA · doi:10.1001/jama.1995.03520470073035 · Cited by 118
Turetschek, K., Preda, A., Novikov, V., Brasch, R. C., Weinmann, H. J., Wunderbaldinger, P., & Roberts, T. P. L. (2004) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20049 · Cited by 114
Carcinoembryonic Antigen in Staging and Follow-Up of Patients with Solid Tumors
Ballesta, A. M., Molina, R., Filella, X., Jo, J., & Giménez, N. (1995) · Tumor Biology · doi:10.1159/000217926 · Cited by 111
Interstitial transport of rabbit and sheep antibodies in normal and neoplastic tissues.
Clauss, M. A., & Jain, R. K. (1990) · PubMed · Cited by 110
Ng, C. M., Stefanich, E. G., Anand, B. S., Fielder, P. J., & Vaickus, L. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8814-3 · Cited by 109
Nicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implications.
Lee, I., Boucher, Y., & Jain, R. K. (1992) · PubMed · Cited by 105
The fate of antibodies bound to the surface of tumor cells in vitro.
Kyriakos, R. J., Shih, L. B., Ong, G. L., Patel, K., Goldenberg, D. M., & Mattes, M. J. (1992) · PubMed · Cited by 102
Nakahara, T., Norberg, S. M., Shalinsky, D. R., Hu‐Lowe, D. D., & McDonald, D. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-0923 · Cited by 102
Processing of antibody-radioisotope conjugates after binding to the surface of tumor cells
Mattes, M. J., Griffiths, G. L., Diril, H., Goldenberg, D. M., Ong, G. L., & Shih, L. B. (1994) · Cancer · doi:10.1002/1097-0142(19940201)73:3+<787::aid-cncr2820731307>3.0.co;2-5 · Cited by 98
Ballangrud, Å., Yang, W., Charlton, D. E., McDevitt, M. R., Hamacher, K. A., Panageas, K. S., Ma, D., Bander, N. H., Scheinberg, D. A., & Sgouros, G. (2001) · PubMed · Cited by 98
Krol, A., Maresca, J., Dewhirst, M. W., & Yuan, F. (1999) · PubMed · Cited by 97
Kenanova, V. E., Olafsen, T., Williams, L. E., Ruel, N. H., Longmate, J., Yazaki, P. J., Shively, J. E., Colcher, D. M., Raubitschek, A. A., & Wu, A. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-0454 · Cited by 94
Eskey, C. J., Koretsky, A. P., Domach, M. M., et al. (1992) · PubMed · Cited by 93
Ng, C. M., Joshi, A., Dedrick, R. L., Garovoy, M. R., & Bauer, R. J. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-5642-4 · Cited by 92
Antibody-directed enzyme prodrug therapy (ADEPT) for cancer
Bagshawe, K. D., Sharma, S. K., & Beǵent, R. H. J. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.11.1777 · Cited by 81
Measurement of macromolecular diffusion coefficients in human tumors
Brown, E. B., Boucher, Y., Nasser, S. M., & Jain, R. K. (2004) · Microvascular Research · doi:10.1016/j.mvr.2004.02.001 · Cited by 78
Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate.
LeBerthon, B., Khawli, L. A., Alauddin, M. M., Miller, G. K., Charak, B. S., Mazumder, A., & Epstein, A. L. (1991) · PubMed · Cited by 77
Behr, T. M., Memtsoudis, S. G., Sharkey, R. M., Blumenthal, R. D., Dunn, R. M., Gratz, S., Wieland, E., Nebendahl, K., Schmidberger, H., Goldenberg, D. M., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980831)77:5<787::aid-ijc19>3.0.co;2-z · Cited by 66
Lin, Y., Pagel, J. M., Axworthy, D. B., Pantelias, A., Hedin, N., & Press, O. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3443 · Cited by 63
A two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragments
Ferl, G. Z., Kenanova, V. E., Wu, A. M., & DiStefano, J. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0072 · Cited by 62
Blumenthal, R. D., Fand, I., Sharkey, R. M., et al. (1991) · Cancer Immunology Immunotherapy · doi:10.1007/bf01741594 · Cited by 57
Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
Sharkey, R. M., Karacay, H., Richel, H., McBride, W. J., Rossi, E. A., Chang, K., Yeldell, D., Griffiths, G. L., Hansen, H. J., & Goldenberg, D. M. (2003) · PubMed · Cited by 51
Yao, Z., Garmestani, K., Wong, K. J., Park, L. S., Dadachova, E., Yordanov, A. T., Waldmann, T. A., Eckelman, W. C., Paik, C. H., & Carrasquillo, J. A. (2001) · PubMed · Cited by 51
Zuckier, L. S., Berkowitz, E., Sattenberg, R. J., Zhao, Q., Deng, H. F., & Scharff, M. D. (2000) · PubMed · Cited by 48
Lustig, H. J., & Bianco, C. (1976) · The Journal of Immunology · doi:10.4049/jimmunol.116.1.253 · Cited by 45
Bryan, J. N., Jia, F., Mohsin, H., Sivaguru, G., Miller, W. H., Anderson, C. J., Henry, C. J., & Lewis, M. R. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.05.006 · Cited by 43
Melkko, S., Halin, C., Borsi, L., Zardi, L., & Neri, D. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03927-5 · Cited by 43
Wenning, L. A., & Murphy, R. M. (1999) · Biotechnology and Bioengineering · Cited by 37
Kievit, E., Pinedo, H., Schlüper, H., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.81 · Cited by 32
Tabata, Y., Kawai, T., Murakami, Y., & Ikada, Y. (1997) · Drug Delivery · doi:10.3109/10717549709051895 · Cited by 31
Kranenborg, M. H. G. C., Boerman, O. C., Oosterwijk‐Wakka, J. C., de Weijert, M. C. A., Corstens, F. H. M., & Oosterwijk, E. (1998) · International Journal of Cancer · Cited by 27
Effects of cellular pharmacology on drug distribution in tissues
Rippley, R. K., & Stokes, C. L. (1995) · Biophysical Journal · doi:10.1016/s0006-3495(95)79956-8 · Cited by 23
Norum, J. (2006) · Journal of Chemotherapy · doi:10.1179/joc.2006.18.5.532 · Cited by 23
Michel, R. B., Ochakovskaya, R., & Mattes, M. J. (2002) · PubMed · Cited by 23
Khawli, L. A., Hu, P., & Epstein, A. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2310 · Cited by 18
Kinuya, S., Yokoyama, K., Kawashima, A., Hiramatsu, T., Konishi, S., Shuke, N., Watanabe, N., Takayama, T., Michigishi, T., & Tonami, N. (2000) · PubMed · Cited by 15
Heterogeneity in antigenic expression and radiosensitivity in human colon carcinoma cell lines
Frykholm, G. J., Glimelius, B. L. G., Richter, S., & Carlsson, J. (1991) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02631115 · Cited by 14
Systems biology and the mathematical modelling of antibody-directed enzyme prodrug therapy (ADEPT)
Varner, J. D. (2005) · Systems Biology · doi:10.1049/ip-syb:20050047 · Cited by 6
Cited by
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Nakamura, Y., Mochida, A., Choyke, P. L., & Kobayashi, H. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00437 · Cited by 1,101
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions
Van Straten, D., Mashayekhi, V., De Bruijn, H., Oliveira, S., & Robinson, D. (2017) · Cancers · doi:10.3390/cancers9020019 · Cited by 1,012
Targeting of drugs and nanoparticles to tumors
Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200910104 · Cited by 829
Antibody-Drug Conjugates in Cancer Therapy
Sievers, E. L., & Senter, P. D. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-050311-201823 · Cited by 770
Exploring the next generation of antibody–drug conjugates
Tsuchikama, K., Anami, Y., Ha, S. Y. Y., & Yamazaki, C. M. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00850-2 · Cited by 659
Metadata
- Authors
- Thurber, G. M., Schmidt, M. M., & Wittrup, K. D.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 60
- Issue
- 12
- Pages
- 1421-1434
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2037248548
- Cited by
- 624
- References
- 134
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.